Mitochondrial dysfunction mitigation through lipid enrichment in inflammatory conditions

Overview

Mitochondrial dysfunction is a critical issue in chronic inflammatory conditions, leading to impaired energy production and increased oxidative stress. This research proposes a novel approach to mitigate these effects by enriching mitochondrial membranes with specific lipid species and administering bioactive autacoids derived from these lipids. This strategy aims to enhance mitochondrial bioenergetics and metabolic efficiency, ultimately improving cellular energy production and reducing oxidative stress in high-inflammatory environments.

Technical specifications

• Lipid Enrichment: Enrichment of mitochondrial membranes with essential fatty acid-derived lipids to improve mitochondrial efficiency.
• Bioactive Autacoids: Administration of lipid-derived autacoids to enhance mitochondrial and metabolic functions.
• Validation Methods: Using a double transgenic mouse model, markers of mitochondrial dysfunction such as GDF15 and FGF21 will be assessed. Lipid composition and mitochondrial ultrastructure will be analyzed using advanced techniques like untargeted lipidomics and transmission electron microscopy.
• Applications: Potentially applicable to conditions with high inflammatory burdens, impacting organs like muscle, liver, and adipose tissue.

Technology readiness level

Currently at TRL 4, this technology has been validated in a laboratory environment with ongoing research to further validate and enhance its efficacy in preclinical models.